Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications

Abstract

With use of varenicline as a case study, early communications from the FDA and VHA followed by a labeling change appeared to be associated with a considerable decrease in drug use, which may have been associated with negative public health consequences.